KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precigen (PGEN) Shares Issued (2016 - 2025)

Precigen (PGEN) has disclosed Shares Issued for 13 consecutive years, with $1.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Shares Issued fell 95.55% to $1.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $466000.0, a 101.14% increase, with the full-year FY2024 number at $31.2 million, changed N/A from a year prior.
  • Shares Issued was $1.4 million for Q3 2025 at Precigen, up from -$355000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $120.8 million in Q3 2021 to a low of -$120.4 million in Q4 2021.
  • A 5-year average of $2.2 million and a median of $1000.0 in 2022 define the central range for Shares Issued.
  • Biggest YoY gain for Shares Issued was 7350000.0% in 2023; the steepest drop was 7350000.0% in 2023.
  • Precigen's Shares Issued stood at -$120.4 million in 2021, then surged by 100.0% to $1000.0 in 2022, then tumbled by 7280900.0% to -$72.8 million in 2023, then skyrocketed by 99.18% to -$596000.0 in 2024, then soared by 337.75% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Shares Issued are $1.4 million (Q3 2025), -$355000.0 (Q1 2025), and -$596000.0 (Q4 2024).